BioSniper ranking
Highest BioSniper Signature Score
The BioSniper Signature Score is a transparent, 0–10 composite built entirely from structured fundamentals — cash runway, financial health, pipeline maturity, pipeline breadth, catalyst momentum, and insider signal — with no LLM in the number and every dimension traceable to its underlying fields. This ranking surfaces the highest-scoring companies with adequate data coverage.
- Ranked entities
- 100
- Freshness
- No verified data date available
- Method
- Published source data
Prepared research question
Why is Artiva Biotherapeutics, Inc. — Highest BioSniper Signature Score → ARTV in this position, and what could change the ranking?
Traceable citations · Unknowns marked
- 1Artiva Biotherapeutics, Inc.ARTV · Oncology10.0 / 103 of 6 signals
- 2GH Research PLCGHRS · Oncology10.0 / 103 of 6 signals
- 3CHINA PHARMA HOLDINGS, INC.CPHI · Oncology9.9 / 103 of 6 signals
- 4Parabilis Medicines, Inc.PBLS · Oncology9.9 / 103 of 6 signals
- 5Faeth Therapeutics, Inc.FTH · Oncology9.8 / 103 of 6 signals
- 6CTT PHARMACEUTICAL HOLDINGS, INC.CTTH · Oncology9.6 / 104 of 6 signals
- 7DR REDDYS LABORATORIES LTDRDY · Oncology9.5 / 103 of 6 signals
- 8Elanco Animal Health IncELAN · Immunology9.4 / 103 of 6 signals
- 9Harmony Biosciences Holdings, Inc.HRMY · Oncology9.3 / 105 of 6 signals
- 10TG THERAPEUTICS, INC.TGTX · Oncology9.3 / 105 of 6 signals
- 11MAIA Biotechnology, Inc.MAIA · Oncology9.1 / 105 of 6 signals
- 12Odyssey Therapeutics, Inc.ODTX · Biological products9.1 / 103 of 6 signals
- 13Rallybio CorpRLYB · Oncology9.1 / 105 of 6 signals
- 14Novartis AGNVS · Oncology9.0 / 104 of 6 signals
- 15Zenas BioPharma, Inc.ZBIO · Neurology9.0 / 106 of 6 signals
- 16AYTU BIOPHARMA, INCAYTU · Oncology8.9 / 105 of 6 signals
- 17Journey Medical CorpDERM · Oncology8.9 / 105 of 6 signals
- 18ENANTA PHARMACEUTICALS INCENTA · Oncology8.9 / 105 of 6 signals
- 19Lantheus Holdings, Inc.LNTH · Oncology8.9 / 105 of 6 signals
- 20Monopar TherapeuticsMNPR · Oncology8.9 / 104 of 6 signals
- 21Kailera Therapeutics, Inc.KLRA · Biopharma developer (SEC filing verified)8.8 / 104 of 6 signals
- 22NATURES SUNSHINE PRODUCTS INCNATR · Metabolic8.8 / 103 of 6 signals
- 23Sarepta Therapeutics, Inc.SRPT · Oncology8.8 / 106 of 6 signals
- 24Ascendis Pharma A/SASND · Oncology8.7 / 106 of 6 signals
- 25BIOGEN INC.BIIB · Oncology8.7 / 106 of 6 signals
- 26Compass Therapeutics, Inc.CMPX · Oncology8.7 / 105 of 6 signals
- 27Lipocine Inc.LPCN · Neurology8.7 / 103 of 6 signals
- 28Aldeyra Therapeutics, Inc.ALDX · Oncology8.6 / 105 of 6 signals
- 29CATALYST PHARMACEUTICALS, INC.CPRX · Oncology8.6 / 105 of 6 signals
- 30Baxter International Inc.BAX · Oncology8.5 / 104 of 6 signals
- 31BioNTech SEBNTX · Oncology8.5 / 104 of 6 signals
- 32Innoviva, Inc.INVA · Infectious Disease8.5 / 105 of 6 signals
- 33MiMedx Group IncMDXG · Oncology8.5 / 104 of 6 signals
- 34Emmaus Life Sciences, Inc.EMMA · Oncology8.4 / 104 of 6 signals
- 35PROCEPT BioRobotics CorporationPRCT · Oncology8.4 / 105 of 6 signals
- 36SINOVAC BIOTECH LTDSVA · Immunology8.4 / 103 of 6 signals
- 37Black Diamond Therapeutics, Inc.BDTX · Oncology8.3 / 105 of 6 signals
- 38Kiora Pharmaceuticals Inc.KPRX · Oncology8.3 / 104 of 6 signals
- 39LEXICON PHARMACEUTICALS, INC.LXRX · Oncology8.3 / 105 of 6 signals
- 40TherapeuticsMD, Inc.TXMD · Pain8.3 / 105 of 6 signals
- 41AbbVie Inc.ABBV · Oncology8.2 / 106 of 6 signals
- 42Anika Therapeutics Inc.ANIK · Pain8.2 / 105 of 6 signals
- 43BRISTOL MYERS SQUIBB COBMY · Oncology8.2 / 106 of 6 signals
- 44IDEAYA Biosciences, Inc.IDYA · Oncology8.2 / 106 of 6 signals
- 45Neuphoria Therapeutics Inc.NEUP · Neurology8.2 / 104 of 6 signals
- 46PROTHENA CORP PUBLIC LTD COPRTA · Oncology8.2 / 106 of 6 signals
- 47SUPERNUS PHARMACEUTICALS, INC.SUPN · Oncology8.2 / 106 of 6 signals
- 48Treace Medical Concepts Inc.TMCI · Oncology8.2 / 105 of 6 signals
- 49UNITED THERAPEUTICS CorpUTHR · Oncology8.2 / 106 of 6 signals
- 50VERTEX PHARMACEUTICALS INC / MAVRTX · Oncology8.2 / 106 of 6 signals
- 51Zoetis Inc.ZTS · Pharmaceutical preparations8.2 / 103 of 6 signals
- 52ZEVRA THERAPEUTICS, INC.ZVRA · Rare Disease8.2 / 106 of 6 signals
- 53Aprea Therapeutics, Inc.APRE · Oncology8.1 / 105 of 6 signals
- 54ASTRAZENECA PLCAZN · Oncology8.1 / 105 of 6 signals
- 55BIOMARIN PHARMACEUTICAL INCBMRN · Oncology8.1 / 104 of 6 signals
- 56PFIZER INCPFE · Oncology8.1 / 106 of 6 signals
- 57Q32 Bio Inc.QTTB · Immunology8.1 / 105 of 6 signals
- 58RELMADA THERAPEUTICS, INC.RLMD · Oncology8.1 / 105 of 6 signals
- 59SYNLOGIC, INC.SYBX · Rare Disease8.1 / 105 of 6 signals
- 60Zomedica Corp.ZOMDF · Nephrology8.1 / 105 of 6 signals
- 61ARGENX SEARGX · Oncology8.0 / 105 of 6 signals
- 62Damora Therapeutics, Inc.DMRA · Oncology8.0 / 105 of 6 signals
- 63Incannex Healthcare Inc.IXHL · Neurology8.0 / 104 of 6 signals
- 64LB PHARMACEUTICALS INCLBRX · Neurology8.0 / 104 of 6 signals
- 65MYRIAD GENETICS INCMYGN · Oncology8.0 / 105 of 6 signals
- 66Oncotelic Therapeutics, Inc.OTLC · Oncology8.0 / 104 of 6 signals
- 67Viatris IncVTRS · Oncology8.0 / 106 of 6 signals
- 68XBiotech Inc.XBIT · Oncology8.0 / 103 of 6 signals
- 69Alkermes plc.ALKS · Oncology7.9 / 106 of 6 signals
- 70Alto Neuroscience, Inc.ANRO · Neurology7.9 / 104 of 6 signals
- 71ArriVent BioPharma, Inc.AVBP · Oncology7.9 / 105 of 6 signals
- 72Hemab Therapeutics Holdings, Inc.COAG · Hematology7.9 / 105 of 6 signals
- 73Filana Therapeutics Inc.FLNA · Oncology7.9 / 105 of 6 signals
- 74Structure Therapeutics Inc.GPCR · Oncology7.9 / 106 of 6 signals
- 75Jazz Pharmaceuticals plcJAZZ · Oncology7.9 / 106 of 6 signals
- 76PTC THERAPEUTICS, INC.PTCT · Oncology7.9 / 106 of 6 signals
- 77RIGEL PHARMACEUTICALS INCRIGL · Oncology7.9 / 106 of 6 signals
- 78SELLAS Life Sciences Group, Inc.SLS · Oncology7.9 / 105 of 6 signals
- 79BIO-TECHNE CorpTECH · Oncology7.9 / 103 of 6 signals
- 80VYNE Therapeutics Inc.YARW · Immunology7.9 / 104 of 6 signals
- 81ACADIA PHARMACEUTICALS INCACAD · Oncology7.8 / 106 of 6 signals
- 82Arcturus Therapeutics Holdings Inc.ARCT · Oncology7.8 / 105 of 6 signals
- 83Actinium Pharmaceuticals, Inc.ATNM · Oncology7.8 / 104 of 6 signals
- 84BIOCRYST PHARMACEUTICALS INCBCRX · Oncology7.8 / 106 of 6 signals
- 85Celldex Therapeutics, Inc.CLDX · Oncology7.8 / 105 of 6 signals
- 86Grifols S.A.GRFS · Oncology7.8 / 105 of 6 signals
- 87IMMUCELL CORP /DE/ICCC7.8 / 105 of 6 signals
- 88Keros Therapeutics, Inc.KROS · Oncology7.8 / 106 of 6 signals
- 89Novo Nordisk A/SNVO · Oncology7.8 / 105 of 6 signals
- 90Atrium Therapeutics Inc.RNA · Neurology7.8 / 103 of 6 signals
- 91Shattuck Labs, Inc.STTK · Oncology7.8 / 106 of 6 signals
- 92Trevi Therapeutics, Inc.TRVI · Oncology7.8 / 105 of 6 signals
- 93ANI PHARMACEUTICALS INCANIP · Neurology7.7 / 106 of 6 signals
- 94Perspective Therapeutics, Inc.CATX · Oncology7.7 / 104 of 6 signals
- 95Cronos Group Inc.CRON · Cardiovascular7.7 / 103 of 6 signals
- 96GERON CORPGERN · Oncology7.7 / 105 of 6 signals
- 97HUTCHMED (China) LimitedHCM · Oncology7.7 / 103 of 6 signals
- 98Incyte Corp.INCY · Oncology7.7 / 106 of 6 signals
- 99IOVANCE BIOTHERAPEUTICS, INC.IOVA · Oncology7.7 / 105 of 6 signals
- 100ELI LILLY & CoLLY · Oncology7.7 / 106 of 6 signals
Ranked by the BioSniper Signature Score (0–10 average of up to 6 structured-data dimensions). Companies with fewer than 3 scored dimensions are excluded to avoid thin-coverage noise.
Frequently asked questions
How is the BioSniper Signature Score calculated?
It averages up to six 0–10 dimensions derived purely from structured data: cash runway, financial health, pipeline maturity, pipeline breadth, catalyst momentum, and insider signal. There is no language model in the number — each dimension traces to specific data fields.
What does data coverage mean for the score?
A dimension with no underlying data shows N/A rather than a fake zero, and the composite is only computed when enough dimensions are scorable — so a high score reflects genuine coverage, not a lucky single metric.
Is the Signature Score investment advice?
No. It is a transparent, structured-data summary meant for research and comparison, not a recommendation. Every input is inspectable so you can disagree with it.
From ranked signal to decision rule
Decide how this ranking should affect your thesis
Turn the ranking field into a criterion, add your own thresholds, and require supporting company evidence before it influences a decision.